Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06199518
Other study ID # 34619/4/21
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 1, 2021
Est. completion date April 1, 2023

Study information

Verified date December 2023
Source Tanta University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

a prospective comparative study designed to compare the outcomes of transperitoneal Laparoscopic ureterolithotomy (T-LUL), mini-percutaneous antegrade ureteroscopy (A-URS) and retrograde ureteroscopy (R-URS) in treating patients with LPUS (15-20 mm). the following parameters were assessed and compared (demographic data and stones characteristics, Stone free rate and complications)


Description:

we aimed in the current study to comprehensively evaluate and to compare the outcome of transperitoneal laparoscopic ureterolithtomy, retrograde ureteroscopy and mini-percutaneous antegrade ureteroscopy for management of large proximal ureteric stone (15 -20 mm) with regards to; operative time, stone free rate, success rate, hospital stay and complications. A total of 105 participants were enrolled in the trial between April 2021 and June 2023 to accomplish this. Inclusion criteria for this study included patients who had a single proximal Ureteral stone (between the pelvi ureteric junction and the upper border of the sacroiliac joint) measuring 15-20 mm in diameter. Patients were randomly allocated to receive either TPLU, RURS, or Minin-perc Antegrade URS, with a 1:1:1 allocation ratio. After providing informed permission, the patients were randomly assigned to one of three groups: Group I (35 patients treated with TPLU), Group II (35 patients treated with RURS), and Group III (35 patients not treated with either TPLU or RURS) (Included 35 patients who were treated by Mini-perc Antegrade URS)


Recruitment information / eligibility

Status Completed
Enrollment 105
Est. completion date April 1, 2023
Est. primary completion date December 1, 2022
Accepts healthy volunteers No
Gender All
Age group 26 Years to 65 Years
Eligibility Inclusion Criteria: - Adults patients - large proximal ureteral stones(1.5-2 cm) Exclusion Criteria: - larger stones - multiple stones - bleeding tendency - active UTI - distal stricture

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
transperitoneal laparoscopic ureterolithotomy (T-LUL)/ retrograde flexible ureteroscopy (R-URS) /Antegrade mini-percutaneous flexible ureteroscopy (A-URS)
extraction or fragmentation of large proximal ureteral stones via different minimally invasive procedures

Locations

Country Name City State
Egypt Urolgy Departement, Faculty of Medicine, Tanta University Tanta Outside U.S./Canada

Sponsors (1)

Lead Sponsor Collaborator
Tanta University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary stone free rate (SFR) SFR is defined as no residual stones or fragments = 4 mm. immediate (initial SFR ) and 1 -month later (final SFR)
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04846699 - Triangulation Bulls Eye and Stone Direct Targeting Pcnl
Not yet recruiting NCT05299996 - Flexible URS in Management of Renal Stones in Anomalous Kidney N/A